Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non–small cell lung carcinoma cells to DNA double-strand break–induced cell death

Anya G. Polischouk, Åsa Holgersson, Dali Zong, Bo Stenerlöw, Hanna L. Karlsson, Lennart Möller, Kristina Viktorsson and Rolf Lewensohn
Anya G. Polischouk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Åsa Holgersson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dali Zong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Stenerlöw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna L. Karlsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lennart Möller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristina Viktorsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf Lewensohn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-06-0402 Published August 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2007 to February 2021

AbstractFull-text HTMLPDF
Total162746671585

Cited By

Article Information

Volume 6, Issue 8, pp. 2303-2309

DOI 
https://doi.org/10.1158/1535-7163.MCT-06-0402
PubMed 
17699725

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • June 29, 2007
  • July 11, 2006
  • June 2, 2007
  • Published first August 15, 2007.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Anya G. Polischouk1,
  2. Åsa Holgersson1,
  3. Dali Zong1,
  4. Bo Stenerlöw3,
  5. Hanna L. Karlsson2,
  6. Lennart Möller2,
  7. Kristina Viktorsson1 and
  8. Rolf Lewensohn1
  1. 1Unit of Medical Radiation Biology, Department of Oncology-Pathology, Cancer Centrum Karolinska and 2Unit for Analytical Toxicology, Department of Biosciences at Novum, Karolinska Institutet, Stockholm, Sweden; and 3Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
  1. Requests for reprints: Rolf Lewensohn, Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institutet, SE-171 76 Stockholm, Sweden. Phone: 46-8-51773188; Fax: 46-8-51771000. E-mail: Rolf.Lewensohn{at}ki.se
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 6 (8)
August 2007
Volume 6, Issue 8
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non–small cell lung carcinoma cells to DNA double-strand break–induced cell death
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non–small cell lung carcinoma cells to DNA double-strand break–induced cell death
Anya G. Polischouk, Åsa Holgersson, Dali Zong, Bo Stenerlöw, Hanna L. Karlsson, Lennart Möller, Kristina Viktorsson and Rolf Lewensohn
Mol Cancer Ther August 1 2007 (6) (8) 2303-2309; DOI: 10.1158/1535-7163.MCT-06-0402

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non–small cell lung carcinoma cells to DNA double-strand break–induced cell death
Anya G. Polischouk, Åsa Holgersson, Dali Zong, Bo Stenerlöw, Hanna L. Karlsson, Lennart Möller, Kristina Viktorsson and Rolf Lewensohn
Mol Cancer Ther August 1 2007 (6) (8) 2303-2309; DOI: 10.1158/1535-7163.MCT-06-0402
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A Novel TRAIL-Based Technology for Tumor Therapy
  • Trastuzumab Targeting of Metastatic Esophageal Cancer
  • Mcl-1 Determines the Fate of KSP-Inhibited Cells
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement